Could the examination of psychedelic interpretations across women and men aid understanding of biological/developmental sex differences?
When does ‘healing’ become an ouroboros trap?
A story about my maternal line ~~~ This is my great grandmother Martha Gayer. My mother’s mother’s mother. She died in 2008 at the age of 99, but I didn’t know she was alive at the time or when she died. I was never introduced to her. She lived alone in a psych ward in Iowa, estranged from most of the family. My grandmother hasn’t said much about her or anything to me. All I was told is that she was mad. /// Martha’s mother, Alvina Tanck, migrated alone from Dägeling to Iowa in 1907 in her 20s. Alvina was born from the rape of her mother—the rapist: her mother’s brother-in-law, one of my grandfathers— and deemed ‘illegitimate’ from birth. The farm in Iowa was her fresh start. She had nine children, including Martha. /// I wish I met her. But I can kinda see her smirk on my face.
Why are potential overlaps between recreational and therapeutic often discredited? Can’t recreation be therapeutic in some cases too?
Will off-label psychedelic prescription use be the new recreational or will it mostly be sought for self-directed therapy or therapy with the help of alternative facilitators? Will people—with or without diagnosable mental conditions—prefer off-label use so they can direct/choose the therapeutic style?*
In response to this recent article in Scientific American.
Is it possible to see within the box without getting locked inside?
Why is nonconsensual, compulsory treatment widely accepted in mental healthcare? Why are many in the medical and bioethics community so certain that the “insane” are undoubtedly unfit to choose for themselves? Who is to say? Who is to decide what is the most whole/beautiful/meaningful/ “right” existence of another?
* Thinking specifically about nonconsensual electroconvulsive therapy (ECT) in schizophrenic patients, some who deny their diagnosis and treatment. See the case PBU & NJE v Mental Health Tribunal from 2018 in Victoria. Essentially, the patients won and were freed from forced treatment. For those on the side of patient advocacy and autonomy, this was good news. However, this ruling upset some psychiatrists and bioethicists.
Can the mentally ill, as certain medical systems see them, make rational, autonomous decisions for themselves? Do certain emotions halt capability to reason? Can anyone make autonomous decisions for themselves? Or are we all embedded in and influenced by altered/unaltered choice/default design?
Fifteen micrograms of acid, on a sliver of paper, washed down with a glass of water. This is my medicine of choice.
I microdosed 1P-LSD from April to December 2017 following a regimen: one day on, threeish days off. It’s been over a year since I stopped that routine and tapered my dosing to as-needed for mood support.
Eight months is a bit longer than most ~microdosing experts~ recommend. Online sources typically suggest six weeks or three months, but that’s mostly speculative. Any recommendations for continued psychedelic use (and all psychiatric medicine?) are relatively inexpert given our still premature understanding of the brain. When it comes to intimate psychological issues, there is no single cure for what has complex—and largely unknown—causes. No one knows which precise treatment or prescription will work for anyone. Especially in people with discreet or hard-to-diagnose issues, who experience difficulty communicating, or who are especially young or old. It’s all an experiment. That’s what the medical community has been doing, as well as a few rogue individuals.
Testing, and reflecting. Continue reading “Dosing after microdosing”
Psychedelic researchers, advocates, and skeptics alike met on February 13th, 2019 in Melbourne for the Mind Medicine Australia launch. Fresh from San Francisco and eager to meet people in this city also interested in psychedelic medicine, I bought an early-bird ticket.
February 13th, 2019, 5:30 PM. At this point in life getting ready to go out involves more time bopping around with acid under my tongue than looking in the mirror. Microdosing quells my zapping nerves and oftentimes overactive mind, especially before larger gatherings.
So I took a small dose before biking to the University of Melbourne for the Mind Medicine launch. The bats weren’t out yet, but they would be soon, and the air was a perfect 23°C. I locked my bike, tried to tame my helmet hair, and entered the Sidney Myer Asia Centre. Immediately greeted, thick lashes ushered me to the left. More smiling eyes appeared around the corner, showing the way upstairs. I entered the full, bustling theater.
There were only a few seats left. Everyone was finding their space, finding their friends. I sat down in the back and observed the crowd. No matter if it’s in Melbourne, London, Berlin, or San Francisco, the general attitude and sense of psychedelic conferences remains the same: compassionate, curious, positive, and present. There’s this shared understanding, communicated with kind and sometimes cheeky glances that say: “We’ve seen a glimpse of the possible. That’s why we’re all here.” It’s usually a clash of characters, buttoned-up scientists, artists. The kind of people you might bond with at a music festival and never see again are there, anticipating a lineup of lectures.
Sound cultish? It really shouldn’t. People from all edges of the earth have been interested in psychedelic medicine and its potential for millennia. Many aboriginal people wonder what took us so long to make the connection. This goes beyond a Reddit thread.
“Hi neighbor,” the man next to me introduced himself. He was wearing a sheen suit and said he wanted a job.